BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23220289)

  • 1. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
    Chaturvedi RK; Beal MF
    Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
    Schapira AH; Olanow CW; Greenamyre JT; Bezard E
    Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and mitochondrial dysfunction in the central nervous system.
    Cardinali DP; Pagano ES; Scacchi Bernasconi PA; Reynoso R; Scacchi P
    Horm Behav; 2013 Feb; 63(2):322-30. PubMed ID: 22391273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.
    Naia L; Ribeiro MJ; Rego AC
    Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic approaches for neuroprotection in Parkinson's disease.
    Beal MF
    Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.
    Chen CM
    Chang Gung Med J; 2011; 34(2):135-52. PubMed ID: 21539755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
    Browne SE
    Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
    Franco-Iborra S; Vila M; Perier C
    Neuroscientist; 2016 Jun; 22(3):266-77. PubMed ID: 25761946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease.
    Beal MF
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S189-94. PubMed ID: 20082988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic role of coenzyme Q(10) in Parkinson's disease.
    Shults CW
    Pharmacol Ther; 2005 Jul; 107(1):120-30. PubMed ID: 15963354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
    Park JS; Davis RL; Sue CM
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial approaches for neuroprotection.
    Chaturvedi RK; Beal MF
    Ann N Y Acad Sci; 2008 Dec; 1147():395-412. PubMed ID: 19076459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of mitochondria in the pathogenesis of Huntington's disease].
    Karachitos A; Gałgańska H; Kmita H
    Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.